The identification of tumoral CXCL12 as a differentially regulated cytokine in the pancreatic TME indicated a sex-specific role for the targetable CXCR4-CXCL12 axis in patients with PDA. This evidence concerns the gene CXCR4 and Patent ductus arteriosus.